Feasibility, tolerability, and preliminary effectiveness of an accelerated bilateral intermittent theta-burst stimulation protocol in adults with posttraumatic stress disorder and comorbid depressive disorder following mild traumatic brain injury

= .002). At Follow-up, response was 35.7% (PHQ-9), 50.0% (PCL-5), and 44.4% (GAD-7); remission was 35.0%, 33.3%, and 44.4%. Overall improvement increased from Post-treatment to Follow-up; 20.0%-28.6% first met criterion at Follow-up. AB-iTBS protocol was feasible, tolerated without documented adverse events, and associated with short-term improvement across depressive, posttraumatic, anxiety, and perceived-stress domains.